Anti- Saccharomyces Cerevisiae Antibodies: A Stable Marker for Crohn's Disease During Steroid and 5-Aminosalicylic Acid Treatment
Alexander Teml(Statistics Austria), Walter Reinisch(Medical University of Vienna), Herbert Lochs(Humboldt-Universität zu Berlin), Verena Kratzer(Medical University of Vienna), Barbara Schneider(Altonaer Kinderkrankenhaus), Gary L. Norman(Nova Medical (United States)), Alfred Gangl(University of Vienna), Harald Vogelsang(Medical University of Vienna)
Cited by 63
Related Papers
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
|Cell|2018|2.8k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Mucosal flora in inflammatory bowel disease
|Gastroenterology|2002|1.3k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765